-Outlook An ambitious drive to eliminate or control a host of diseases, including measles, which affects lakhs of people and leave many killed every year will be launched, Health Minister Harsh Vardhan today said. Vardhan said the government was already working towards eliminating measles by 2015 and Rubella, also known as German measles, and 'Kala-azar' or black fever by 2015. It also aims to eliminate parasitic disease Filaria by 2015 and Leprosy at...

-The Indian Express Prime Minister Narendra Modi's US visit is likely to throw up highly contentious intellectual property rights issues. Indeed, for the last several years, US drug majors and their European counterparts have lobbied hard to demonise the Indian patent regime. But the government must continue to defend the law and stand its ground. Particularly since our own industrial moguls have caved in and are less vocal about their opposition...

-The Times of India NEW DELHI: Faced with the scary prospect of losing lives to simple infections in the future, India is finally waking up to the dangers of reckless antibiotic use. The Indian Medical Association, a pan-India voluntary organization of doctors, will on Sunday launch a nationwide awareness programme on overuse of these live-savers, a practice that has led to emergence of drug-resistant organisms. IMA will also ask fellow practitioners to...

-PTI Srinagar: When the floods wreaked havoc in Kashmir and plunged most parts of the Valley into darkness, few doctors at a lone maternity care hospital in Srinagar, lent a ray of light to people's lives by performing birth surgeries under candlelight. Doctors at the Lal Ded Hospital, whose ground floor was submerged by flood waters from Jhelum, performed six deliveries under the candlelight as the electricity supply to the hospital was...

-The Telegraph New Delhi: A government agency has blocked its own pledge to impose price control on more medicines by withdrawing guidelines that it had used in July this year to cap prices of Drugs used to treat diabetes and cardiovascular diseases. The National Pharmaceutical Pricing Authority (NPPA) has withdrawn the guidelines issued under Paragraph 19 of the Drug Price Control Order that it had used in July this year to cap...